Cargando…

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR

BACKGROUND: Overexpression of fibroblast growth factor receptor 3 (FGFR3) has been linked to tumor progression in many types of cancer. The role of FGFR3 in melanoma remains unclear. In this study, we aimed to uncover the role of FGFR3 in the growth and metastasis of melanoma. METHODS: FGFR3 knockdo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lei, Zhang, Shuai, Li, Hao, Chou, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796326/ https://www.ncbi.nlm.nih.gov/pubmed/31619201 http://dx.doi.org/10.1186/s12885-019-6161-8

Ejemplares similares

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
por: Terp, Mikkel G., et al.
Publicado: (2021)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
por: Raoof, Sana, et al.
Publicado: (2019)

Polygonum cuspidatum inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways
por: Zhao, Jun, et al.
Publicado: (2022)

Overexpression of TRAF4 promotes lung cancer growth and EGFR‐dependent phosphorylation of ERK5
por: He, Siwei, et al.
Publicado: (2022)

Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells
por: Lev, D C, et al.
Publicado: (2004)

CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation
por: Wang, Junpu, et al.
Publicado: (2023)

Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration
por: Wang, Kun, et al.
Publicado: (2019)

Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth
por: Allahverdi, Amir, et al.
Publicado: (2020)

Filamin A regulates EGFR/ERK/Akt signaling and affects colorectal cancer cell growth and migration
por: Wang, Kun, et al.
Publicado: (2022)

Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression
por: Xu, Yunfei, et al.
Publicado: (2016)

The ILEI/LIFR complex induces EMT via the Akt and ERK pathways in renal interstitial fibrosis
por: Zhou, Jieqing, et al.
Publicado: (2022)

Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
por: Sheng, Weiwei, et al.
Publicado: (2017)

PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades
por: Yan, Yongrong, et al.
Publicado: (2021)

SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR
por: Thomas, J. Terrig, et al.
Publicado: (2016)

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
por: Yajima, Ichiro, et al.
Publicado: (2012)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG(35‐55)‐induced EAE through ERK and Akt signalling
por: Kamali, Salar, et al.
Publicado: (2021)

Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased Heparanase Expression and Phosphorylation of ERK and AKT Pathways
por: Zhang, Yi, et al.
Publicado: (2017)

RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway
por: Li, Mingyang, et al.
Publicado: (2021)

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
por: Peng, Mei, et al.
Publicado: (2016)

Clonorchis sinensis Granulin Promotes Malignant Transformation of Hepatocyte Through EGFR-Mediated RAS/MAPK/ERK and PI3K/Akt Signaling Pathways
por: Wang, Caiqin, et al.
Publicado: (2021)

FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling
por: Daly, C, et al.
Publicado: (2017)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
por: Cheng, Lanming, et al.
Publicado: (2020)

Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005)

Livin participates in resistance to trastuzumab therapy for breast cancer through ERK1/2 and AKT pathways and promotes EMT-like phenotype
por: Li, Fan, et al.
Publicado: (2018)

Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh-7 cells by regulating the ERK-VEGF/MMP9 signaling pathway
por: Chen, Yafei, et al.
Publicado: (2019)

MiR-338-5p Inhibits EGF-Induced EMT in Pancreatic Cancer Cells by Targeting EGFR/ERK Signaling
por: Sun, Jian, et al.
Publicado: (2021)

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway
por: Xu, Jinming, et al.
Publicado: (2023)

ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing
por: Crosbie, Philip A J, et al.
Publicado: (2016)

Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities
por: Ren, Mingqiang, et al.
Publicado: (2012)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
por: Wang, Xiaomeng, et al.
Publicado: (2019)

Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model
por: Ding, Chenbo, et al.
Publicado: (2016)

Growth charts in FGFR2- and FGFR3-related faciocraniosynostoses
por: Ea, Caroline, et al.
Publicado: (2022)

Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy
por: Lee, Soohyeon, et al.
Publicado: (2011)

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
por: Han, Shujun, et al.
Publicado: (2018)

Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma
por: Xiong, Shida, et al.
Publicado: (2022)

Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.
por: Luqmani, Y. A., et al.
Publicado: (1992)

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
por: Magkou, Christina, et al.
Publicado: (2008)

Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation
por: Vega, Mario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tilpmvm98aqsqsjh4mdoi8crv8